$SNPS

Synopsys is Hot Again But a Pattern Has Emerged

Synopsys (SNPS) shares rose 16.97% in a week, with fiscal Q3 revenue up 42.4% YoY to $2.48B and EPS beating estimates. The company raised full-year guidance, but past earnings beats led to selloffs. Analysts see 16.6% upside, with a consensus target of $569.78. SNPS trades at $488.47, facing risks like debt and export controls.

Original reporting
Published Oct 6, 2026, 12:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 12:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Synopsys is Hot Again But a Pattern Has Emerged — source image
Decision brief

The 30-second read

$SNPSBearishLow
01

Why it matters

The piece offers no new data; it reinforces the known risk of sell‑offs after earnings beats.

02

Market read

Recap of known earnings data; limited actionable insight for traders.

03

What to watch

Potential upside from upcoming 2027 product roll‑outs and AI‑driven royalty deals not yet reflected in price.

Relevance 4/10Novelty 2/10Timing: none

Background

Synopsys' Q3 results and guidance were released on Aug 26, 2026. The article repeats those numbers and adds historical post‑earnings price behavior.

Company-level read

Ticker impact

$SNPSBearishMedium confidence
Context

The article recaps Synopsys' recent earnings beat and guidance, which were released over a month ago, and discusses the historical post‑earnings sell‑offs.

Expected impact

potential downside as investors may sell on the pattern of post‑earnings declines

Evidence & confidence

Historical data shows the stock falls after each earnings beat; no fresh catalyst to reverse the trend.

Market effects

The EDA sector may see continued scrutiny of earnings‑beat sell‑offs, but no sector‑wide shift.

U.S. market only; no broader regional effect.

Limited to investors tracking Synopsys and comparable EDA peers.

Counterpoint

If the company can sustain double‑digit EDA growth and monetize new IP, the pattern may break and the stock could rally.

Key entities

  • Synopsys

    EDA software and silicon IP provider.

Related articles

$SNPSMedAI 8/10

Should $1b Amazon Deal Require Action From Synopsys (SNPS) Investors?

Synopsys (SNPS) announced a multiyear, $1B+ deal with Amazon to expand the use of its EDA, IP, and AI-based engineering tools for custom silicon. The agreement aligns with Synopsys' AI-centric roadmap and long-term financial goals. Analysts highlight potential demand visibility and capital allocation influences, while noting risks like Ansys integration and litigation. Current earnings are $1.1B, with forecasts for $2.6B by 2029, implying 13% yearly revenue growth.

$SNPSHigh

Synopsys (SNPS) Announces $1 Billion Accelerated Share Repurchas

Synopsys (SNPS) announced a $1 billion accelerated share repurchase agreement with JPMorgan Chase, aiming to buy back 1.7 million shares initially. The company's shares rose over 1% in pre-market trading. According to GuruFocus, SNPS is modestly undervalued by 24%, with a GF Value of $659.43. The company has a GF Score of 95/100, indicating strong financial health and growth potential. However, insider activity shows no purchases and $48.2 million in sales over the past year.